Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01415583 · ClinicalTrials.gov registry record · NA

Evaluating Perioperative Dexamethasone and the Risk of Bleeding in Tonsillectomy

A NA study, sponsored by Massachusetts Eye and Ear Infirmary.

Completed
Registry status
NA
Development phase
314
Enrollment target

NCT01415583 is a NA study that has completed, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 314 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01415583, a NA study, has completed, sponsored by Massachusetts Eye and Ear Infirmary.

COMPLETED
Registry status
NA
Development phase
314 participants
Enrollment target

Study Summary

Tonsillectomy (removal of the tonsils) is a very common surgery in children. Bleeding after tonsillectomy is one of the risks of this surgery and can be more dangerous in children since they have less blood volume than adults. In order to improve recovery after tonsillectomy, steroids (medication that is a strong anti-inflammatory) are often given during the surgery. Recently, a study showed steroids given at the time of tonsillectomy increase the risk of bleeding significantly over children who did not receive steroids. This finding has raised concerns in the Ear, Nose, and Throat (ENT) community since most ENT's use steroids during tonsillectomy in children. The investigators look to explore this question further. To answer the question of whether perioperative steroid administration significantly affects the rate of post-tonsillectomy bleeding, the investigators propose to test the following hypotheses in a prospective, randomized, blinded placebo-controlled trial: dexamethasone does not cause an increase in post-operative bleeding rate in tonsillectomy.

Interventions

  • DRUG Dexamethasone

Trial Details

FieldValue
Enrollment Target 314 participants
Start Date 2010-07
Est. Completion 2011-11
Phase NA

What the Registry Record Tells You About NCT01415583

The ClinicalTrials.gov registry entry for NCT01415583 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 314 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts Eye and Ear Infirmary, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Dexamethasone is the first listed.

NCT01415583 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01415583 about?

NCT01415583 is a clinical study titled "Evaluating Perioperative Dexamethasone and the Risk of Bleeding in Tonsillectomy". Tonsillectomy (removal of the tonsils) is a very common surgery in children. Bleeding after tonsillectomy is one of the risks of this surgery and can be more dangerous in children since they have less blood volume than adults. In order to improve recovery after tonsillectomy, steroids (medication th...

What is the current status of trial NCT01415583?

This trial is currently completed. It is a NA study. The enrollment target is 314 participants. The study started on 2010-07. Estimated completion is 2011-11.

What interventions are being tested in trial NCT01415583?

The interventions under investigation include: Dexamethasone (DRUG).

Who is sponsoring clinical trial NCT01415583?

This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.